What is it about?
The paper shows that cost-effectiveness in migrant children is dependent on the background rate of LTBI and the estimated progression rate form LTBI to TB disease. For example, in the study setting, at 10% prevalence rate of LTBI, screening becomes cost-saving with an estimated progression rate of 17% (for more details see the figures in the attached paper).
Featured Image
Read the Original
This page is a summary of: Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country, The International Journal of Tuberculosis and Lung Disease, May 2019, International Union Against Tuberculosis and Lung Disease,
DOI: 10.5588/ijtld.18.0356.
You can read the full text:
Contributors
The following have contributed to this page
